Dear Colleagues:

The first six months of 2012 brought a significant expansion of Implant Direct's manufacturing capacity, product options, customer services and educational opportunities. While many implant companies are experiencing little or no growth, Implant Direct continues to gain market share by offering a broad range of high quality, industry compatible implants and prosthetic components with value pricing. In a recent interview published in Inside Dentistry, June 2012, I discuss how the implant industry is segmented into Discounters, selling on price alone, Premium Priced Companies, discounting only to their larger customers to retain their loyalty and the Value Segment, which Implant Direct is widely acknowledged as having created.

Implant Direct makes innovative application specific implants such as the patented 1-piece ScrewIndirect and makes 2-piece implants with both surgical and/or prosthetic compatibility to those sold by Nobel Biocare, Straumann and Zimmer Dental. Our implants differ from clones selling on price alone, as evident in the Replace/RePlant Comparison Video, by offering improved designs with all-in-1 packaging for added value. For Straumann users, we recently launched the SwishPlus implant, offering 100% surgical and prosthetic compatibility with Straumann's tissue level implants, but with significant design and packaging improvements. Keeping with our value proposition, the SwishPlus represents a 69% cost savings compared to Straumann. The next major new product launch set for the 4th quarter of 2012 is the InterActive System with over 300 new parts, including a full line of abutments compatible with NobelActive and NobelReplace Conical with an innovative (Patent Pending) 2-piece fixture-mount that is a transfer and abutment.

In North America, we were proud to be recognized by a Millennium Research Group Survey as having the highest level of Customer Satisfaction compared to the 6 largest implant companies. The breadth of innovative and industry-compatible products offered by Implant Direct is clearly demonstrated in the "Transforming the Implant Industry" brochure showing our journal ads throughout the year. The extensive clinical applications that our products provide are detailed in the reprint of the 4-part clinical article series "The Changing Reality of Implant Dentistry." The reprint brochure also includes 3 independently published studies documenting a 98-100% success rate.

I encourage you to visit www.implantdirect.com and learn more about our products as well as practice building opportunities. Our content-rich website includes many clinical videos and over 70 3-D graphic videos covering surgical, prosthetic, laboratory and team approach procedures. Please take the opportunity to watch my two hour, July 2011 New York lecture now available with online CE credits for those who wish to register and answer 13 questions covered in this lecture.